Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

Antimicrobial Agents and Chemotherapy
D A RouseS L Morris

Abstract

Resistance to isoniazid in Mycobacterium tuberculosis has been associated with mutations in genes encoding the mycobacterial catalase-peroxidase (katG) and the InhA protein (inhA). Among the 26 isoniazid-resistant clinical isolates evaluated in this study, mutations in putative inhA regulatory sequences were identified in 2 catalase-positive isolates, katG gene alterations were detected in 20 strains, and 4 isolates had wild-type katG and inhA genes. Mutations in the katG gene were detected in all 11 catalase-negative isolates: one frameshift insertion, two partial gene deletions, and nine different missense mutations were identified. An arginine-to-leucine substitution at position 463 was detected in nine catalase-positive isolates. However, site-directed mutagenesis experiments demonstrated that the presence of a leucine at codon 463 did not alter the activity of the M. tuberculosis catalase-peroxidase and did not affect the capacity of this enzyme to restore isoniazid susceptibility to isoniazid-resistant, KatG-defective Mycobacterium smegmatis BH1 cells. These studies further support the association between katG and inhA gene mutations and isoniazid resistance in M. tuberculosis, while also suggesting that other undefined m...Continue Reading

References

Aug 11, 1992·Annals of Internal Medicine·S W DooleyD E Snider
Aug 21, 1992·Science·B R Bloom, C J Murray
Jan 11, 1991·Methods in Enzymology·W R JacobsB R Bloom
Sep 1, 1988·Journal of Bacteriology·B L Triggs-RaineP C Loewen
Mar 1, 1995·Molecular Microbiology·T M WilsonD M Collins
Aug 1, 1994·Antimicrobial Agents and Chemotherapy·J L Rosner, G Storz
Feb 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·B P VareldzisA Kochi
Feb 25, 1993·The New England Journal of Medicine·T R FriedenS W Dooley

❮ Previous
Next ❯

Citations

Nov 11, 2003·Journal of Microbiological Methods·Laura RindiCarlo Garzelli
Jan 10, 2002·Infectious Disease Clinics of North America·T F Smith
Feb 1, 1997·International Journal of Antimicrobial Agents·B Heym, S T Cole
Jul 8, 2000·Microbes and Infection·R A Slayden, C E Barry
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Adnan T AbalEiman Mokaddas
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Manzour Hernando HazbónDavid Alland
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A S LeeS Y Wong
Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Rosanna MaccariMaria Gabriella Vigorita
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Joseph A DeVito, Sheldon Morris
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Glenn P MorlockRobert C Cooksey
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Srinivas V RamaswamyEdward A Graviss
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Stéphanie Ducasse-CabanotAnnaïk Quémard
Jun 11, 1998·Emerging Infectious Diseases·A RattanN Ahmad
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangV Deretic
Feb 14, 2016·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Luita Nice Café OliveiraFabrício Rios-Santos
Nov 5, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shu-Ting TsengZhi-Yuan Shi
Sep 29, 2012·Tuberculosis·Mae Newton-Foot, Nicolaas C Gey van Pittius
Oct 27, 1998·Mayo Clinic Proceedings·F R Cockerill
Aug 6, 2014·Journal of Theoretical Biology·Yolandy LemmerHendrik Viljoen
Feb 13, 2007·Bioorganic & Medicinal Chemistry·Yves L Janin
Jan 8, 2010·Protein Science : a Publication of the Protein Society·Christine E CadeReza A Ghiladi
Jul 14, 2004·Protein Expression and Purification·Nancy L WengenackFrank Rusnak
Jun 15, 2004·International Journal of Antimicrobial Agents·Laura HerreraM Soledad Jiménez
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·C E BarryK Mdluli
Jan 9, 2004·Clinics in Laboratory Medicine·Harri J Marttila, Hanna Soini
Sep 1, 2012·International Journal of Mycobacteriology·Senia Rosales-KlintzSven E Hoffner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.